How to address racial disparities in clinical trial dataIn the US, fewer than three per cent of eligible patients participate in clinical trials – a figure Share XHow to address racial disparities in clinical trial datahttps://pharmaphorum.com/views-analysis-patients/utilising-technology-racial-disparities-clinical-trial-data/
Patient Insights: Colorectal CancerEvent planner and colorectal cancer survivor Kim Hall-Jackson tells us how she hopes to improve rates of diagnosis, Share XPatient Insights: Colorectal Cancerhttps://pharmaphorum.com/views-analysis-patients/patient-insights-colorectal-cancer/
Q&A: Accenture’s Keena Patel on optimising patient engagementWe speak to Keena Patel, a managing director in Accenture’s Life Sciences practice, about how pharmaceutical companies can Share XQ&A: Accenture’s Keena Patel on optimising patient engagementhttps://pharmaphorum.com/views-analysis-patients/accentures-keena-patel-patient-engagement/
Joined up thinking and innovation will boost drug development in rare diseasesFresh thinking and greater collaboration at the European level could accelerate the much-needed development of treatments and cures Share XJoined up thinking and innovation will boost drug development in rare diseaseshttps://pharmaphorum.com/views-analysis-patients/innovation-drug-development-rare-diseases/
Where next for patient centricity in pharma?As patient centricity seems to be hitting a slump, Paul Tunnah lays out the key factors companies need Share XWhere next for patient centricity in pharma?https://pharmaphorum.com/views-analysis-patients/where-next-for-patient-centricity-in-pharma/
A blueprint for building a patient-centric pharma companyWhile the industry appears united in its commitment to patient centricity, the practicalities of embedding the ethos into Share XA blueprint for building a patient-centric pharma companyhttps://pharmaphorum.com/views-analysis-patients/whitepaper-provides-a-blueprint-to-building-a-patient-centricity-company/
FCS: A life-limiting conditionGP Karishma Patel tells us about the daily challenges of living with the ultra-rare condition Familial Chylomicronaemia Syndrome Share XFCS: A life-limiting conditionhttps://pharmaphorum.com/views-analysis-patients/fcs-a-life-limiting-condition/
eyeforpharma Patient Summit Europe roundupeyeforpharma’s Patient Summit Europe brought together leading patient innovators from industry and patient associations for two days of Share Xeyeforpharma Patient Summit Europe rounduphttps://pharmaphorum.com/views-analysis-patients/eyeforpharma-patient-summit-europe-roundup/
Getting MS diagnosis rightMS advocate Trishna Bharadia explains how diagnosis needs to change and why pharma shouldn’t be using the word Share XGetting MS diagnosis righthttps://pharmaphorum.com/views-analysis-patients/getting-ms-diagnosis-right/
